-
Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyurea
Haggenburg, S., Pothast, C. R., Hofsink, Q., Haverkate, N. J. E., Bhoekhan, M. S., Claireaux, M., van Binnendijk, R. S., den Hartog, G., Lissenberg-Witte, B. I., de Vries, R. D., Van Tuijn, C. F. J., Biemond, B. J., Nur, E., GeurtsvanKessel, C., Mutsaers, P. G. N. J., Broers, A. E. C., Goorhuis, A., Nijhof, I. S., van Gils, M. & Heemskerk, M. H. M. & 2 others, , 26 Nov 2025, (E-pub ahead of print) In: BLOOD ADVANCES.Research output: Contribution to journal › Article › Academic › peer-review
-
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines
Pothast, C. R., Hofsink, Q., Haggenburg, S., Dijkland, R. C., van de Meent, M., van Dijk, K., Bhoekhan, M. S., Haverkate, N. J. E., van Meerloo, J., Falkenburg, J. H. F., de Groen, R. A. L., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Lissenberg-Witte, B. I., Kater, A. P., Smits, G. P., Wouters, D. & van Leeuwen, E. M. M. & 13 others, , 1 Nov 2025, In: Haematologica. 110, 11, p. 2799-2805 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
